BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38367066)

  • 1. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
    Polat MC; Sönmez Ç; Yarali N; Özbek NY
    Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.
    Hatzistilianou M; Rekliti A; Athanassiadou F; Catriu D
    Inflamm Res; 2010 May; 59(5):339-47. PubMed ID: 19806318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
    Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
    Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
    Srinivasan A; Kumar N; Scott JX
    Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
    van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
    Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of serum C-reactive protein (CRP) over time in pediatric cancer patients with febrile illness and its relevance to identified pathogen.
    Sklavou R; Karavanaki K; Critselis E; Kossiva L; Giannaki M; Tsolia M; Papadakis V; Papargyri S; Vlachou A; Karantonis F; Gourgiotis D; Polychronopoulou S
    Clin Biochem; 2012 Oct; 45(15):1178-82. PubMed ID: 22820435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
    Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
    Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
    Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
    Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia.
    Aggarwal R; Bansal D; Bansal F; Nanda N; Ray P; Trehan A; Marwaha RK
    Indian J Med Microbiol; 2013; 31(3):226-9. PubMed ID: 23883706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
    Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
    Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
    Abrahamsson J; Påhlman M; Mellander L
    Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
    Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
    Baraka A; Zakaria M
    Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
    Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
    Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.